POLICY BRIEFINGS


FDA Issues


ccording to Senator Mike Enzi, the Senate HELP Committee will include in one bill all four FDA/manufacturer user fee agreements covering brand-name drugs, medical devices, generic drugs and biosimilars.  The bills would reauthorize the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA) and create new user fee programs for generic drugs and biosimilar (or follow-on biologic) drugs.


IPAB Repeal Needs Technical Restart in House


The House previously passed H.R. 5, the Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act of 2011, which would repeal the PPACA’s Independent Payment Advisory Board.  Because of a technical glitch, the House was forced to approve a resolution, H.Res. 596, that requests the Senate to return the bill to the House for correction.


Recently Introduced Health Legislation


S. 2227 (TAXATION), to amend the Internal Revenue Code of 1986 to expand and simplify the credit for employee health insurance expenses of small employers; KERRY; to the Committee on Finance, March 22.

H.R. 4242 (HEALTH REFORM), to repeal the Patient Protection and Affordable Care Act, to amend the Public Health Service Act to provide individual and group market reforms to protect health insurance consumers, and for other purposes; HECK; jointly, to the committees on Energy and Commerce, Ways and Means, Education and the Workforce, the Judiciary, Natural Resources, Rules, House Administration, and Appropriations, March 22.

H.R. 4245 (VETERANS’ HEALTH), to amend Title 38, United States Code, to require the secretary of veterans affairs to reimburse eligible veterans who are entitled to Medicare benefits for Medicare deductibles and other expenses that are owed by the veterans for emergency medical treatment provided in non-Department of Veterans Affairs facilities; DEFAZIO; to the Committee on Veterans’ Affairs, March 22.

H.R. 4246 (VETERANS’ HEALTH), to amend Title 38, U.S. Code, to provide for the expansion of eligibility for veteran reimbursement for emergency treatment provided in non-Department of Veterans Affairs facilities; DEFAZIO; to the Committee on Veterans’ Affairs, March 22.

H.R. 4254 (MEDICARE), to amend Title XVIII of the Social Security Act to enhance Medicare Advantage program integrity; STARK; jointly, to the committees on Ways and Means and Energy and Commerce, March 22.

H. RES. 594 (DISEASE AWARENESS), commending the progress made by anti-tuberculosis programs; ENGEL; jointly, to the committees on Foreign Affairs and Energy and Commerce, March 22.

S. 2236 (DRUGS), to provide for the expedited development and evaluation of drugs designated as breakthrough drugs; BENNET; to the Committee on Health, Education, Labor, and Pensions, March 26.

H. CON. RES. 113 (FEDERAL BUDGET), establishing the budget for the U.S. government for fiscal year 2013 and setting forth appropriate budgetary levels for fiscal year 2012 and fiscal years 2014 through 2022; GARRETT; to the Committee on the Budget, March 26.

S. 2243 (MEDICARE), to establish a program to provide incentive payments to participating Medicare beneficiaries who voluntarily establish and maintain better health; WYDEN; to the Committee on Finance, March 28.

H.R. 4274 (CHILDREN’S HEALTH), to amend Title IV of the Public Health Service Act and Title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act of 2003; ROGERS of Michigan; to the Committee on Energy and Commerce, March 28.

H.R. 4292 (PRESCRIPTION DRUGS), to direct the attorney general to establish uniform standards for the exchange of controlled substance and prescription information for the purpose of preventing diversion, fraud, and abuse of controlled substances and other prescription drugs; ROGERS of Kentucky; to the Committee on Energy and Commerce, March 28.

S. 2254 (PRESCRIPTION DRUGS), to direct the attorney general to establish uniform standards for the exchange of controlled substance and prescription information for the purpose of preventing diversion, fraud, and abuse of controlled substances and other prescription drugs; PORTMAN; to the Committee on Health, Education, Labor, and Pensions, March 29.

S. 2256 (MENTAL HEALTH), to amend the Public Health Service Act to provide grants for community-based mental health infrastructure improvement; REED; to the Committee on Health, Education, Labor, and Pensions, March 29.

S. 2257 (MEDICAID), to increase access to community behavioral health services for all Americans and to improve Medicaid reimbursement for community behavioral health services; STABENOW; to the Committee on Health, Education, Labor, and Pensions, March 29.

S. 2262 (CHILDREN’S HEALTH), to amend the Public Health Service Act to reauthorize and extend the Fetal Alcohol Syndrome prevention and services program, and for other purposes; JOHNSON of South Dakota; to the Committee on Health, Education, Labor, and Pensions, March 29.

S. 2265 (MEDICARE), to amend Title XVIII of the Social Security Act to cover screening computed tomography colonography as a colorectal cancer screening test under Medicare; INHOFE; to the Committee on Finance, March 29.

S. 2281 (RARE DISEASES), to amend the Federal Food, Drug, and Cosmetic Act to strengthen the ability of the Food and Drug Administration to seek advice from external experts regarding rare diseases, the burden of rare diseases, and the unmet medical needs of individuals with rare diseases; WHITEHOUSE; to the Committee on Health, Education, Labor, and Pensions, March 29.

H.R. 4315 (VETERANS’ HEALTH), to amend Title 38, United States Code, to provide for unlimited eligibility for health care for mental illnesses for veterans of combat service during certain periods of hostilities and war; RYAN of Ohio; to the Committee on Veterans’ Affairs, March 29.

H.R. 4324 (TAXATION), to amend the Internal Revenue Code of 1986 to expand the credit for employee health insurance expenses of small employers; KIND; to the Committee on Ways and Means, March 29.

H.R. 4332 (DRUGS), to amend Section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes; PALLONE; to the Committee on Energy and Commerce, March 29.

H.R. 4341 (MILITARY HEALTH), to direct the secretary of defense to establish a working group to review TRICARE policy with respect to providing health care to children and determine how to improve such policy, and for other purposes; STIVERS; to the Committee on Armed Services, March 29.

H. RES. 603 (DISEASE AWARENESS), expressing support for designation of Oct. 2, 2012, as World MRSA Day; BIGGERT; to the Committee on Oversight and Government Reform, March 29.

H. RES. 605 (PUBLIC HEALTH), supporting the goals and ideals of National Public Health Week; ROYBAL-ALLARD; to the Committee on Energy and Commerce, March 29.



April 2, 2012: | Page 1 Page 2 Page 3

SERVICES




BRIEFING ARCHIVE


 -  2018


 +  2017


 +  2016


 +  2015


 +  2014


 +  2013


 +  2012


 +  2011